2013-2014 2014-2015 2015-2016 2016-2017 2017-2018
Browse
by subject...
    Schedule
view...
 

Randall S. Stafford (Professor)

Randall S. Stafford (650) 724-2400
randy.stafford
I'm-not-a-bot
@stanford
Personal bio
Randall S. Stafford, MD, PhD, joined the Stanford Prevention Research Center (SPRC) faculty in 2001. He is an Associate Professor of Medicine and Director of the Program on Prevention Outcomes and Practices in the SPRC. His training includes a PhD in Epidemiology and an MD with subsequent clinical training in Internal Medicine, a specialty in which he is board certified. Dr. Stafford has broad clinical expertise as a practicing primary care internist, substantial epidemiological research expertise, and significant experience evaluating patterns of outpatient practice. He also gained relevant administrative skills as Assistant Director of Primary Care Operations Improvement at Massachusetts General Hospital in Boston. Dr. Stafford sees patients in the Stanford Preventive Cardiology Clinic and the Stanford Internal Medicine Clinic. Dr. Stafford studies cardiovascular disease treatment and prevention, the adoption of new technology and prevention practices, and patterns of physician practice, particularly medication prescribing. His main areas of interest include measuring and improving the quality of outpatient care and disparities in health care by race, gender, age and socioeconomic status. His research emphasizes clinical issues related to cardiovascular diseases, obesity and diabetes, and pharmaceutical policy, and women's health issues. Although he is a national leader in analyzing outpatient quality of care, his recent work has focused on designing and testing interventions to improve outpatient quality of care. Dr. Stafford's research aims to advance scientific understanding of the forces that influence physician and patient behavior. He also has significant expertise in comparative effectiveness research, with a focus on evaluating pharmaceutical alternatives in chronic disease management. In particular, his research and commentaries on off-label drug use have helped shape debate on legal and regulatory strategies aimed at constraining off-label drug use to those clinical situations where it improves patient outcomes.

Currently teaching
CHPR 255: The Responsible Conduct of Research for Clinical and Community Researchers (Autumn, Winter, Spring)
MED 255C: The Responsible Conduct of Research for Clinical and Community Researchers (Autumn, Winter, Spring)
© Stanford University | Terms of Use | Copyright Complaints